NCT00118170
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +83 more
- Locations
-
- Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States
Clinical trial condition
Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.
NCT00118170
NCT00027560
NCT00142181
NCT00003143
NCT00255749
NCT00296023
NCT00787761
NCT00110045
NCT00003938
NCT00003805